trimebutine has been researched along with Intellectual Disability in 1 studies
Trimebutine: Proposed spasmolytic with possible local anesthetic action used in gastrointestinal disorders.
Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loers, G | 1 |
| Appel, D | 1 |
| Lutz, D | 1 |
| Congiu, L | 1 |
| Kleene, R | 1 |
| Hermans-Borgmeyer, I | 1 |
| Schäfer, MKE | 1 |
| Schachner, M | 1 |
1 other study available for trimebutine and Intellectual Disability
| Article | Year |
|---|---|
Amelioration of the abnormal phenotype of a new L1 syndrome mouse mutation with L1 mimetics.
Topics: Animals; Cells, Cultured; Cerebellum; Cerebral Ventricles; Corpus Callosum; Duloxetine Hydrochloride | 2021 |